March 20, 2020 - Dixie Brands and Khiron Life Sciences Mutually Agree to Terminate Joint Venture

DENVER, March 20, 2020 /CNW/ - Today, Dixie Brands Inc. ("Dixie" or "the Company") (CSE: DIXI.U), (OTCQX: DXBRF), (Frankfurt: 0QV), one of the cannabis industry's leading consumer packaged goods ("CPG") companies, confirmed that in light of the contemplated change of control in connection with Dixie's pending transaction with BR Brands, Dixie and Khiron Life Sciences Corp. have mutually agreed to terminate the joint venture that was announced on January 30, 2019.


Dixie Brands Inc. is leading the CPG cannabis industry by championing freedom of choice for consumers around the world. Through its licensed partners, Dixie has been perfecting the art and science of creating award-winning THC and CBD-infused products for nearly a decade. A true multi-state operator currently in California, Colorado, Maryland, Michigan, Nevada and Oklahoma. Dixie's relentless commitment to product innovation from fun to functional has earned the brand a place as one of the industry's most recognized consumer brands.  Dixie's portfolio features over 100 products across more than 15 different product categories representing the industry's finest edibles, beverages, tinctures, topicals and connoisseur grade extractions, as well as world-class CBD-infused wellness products and pet supplements. To find out more about Dixie's innovative products, visit 

SOURCE Dixie Brands, Inc.

For more information, please contact

Media & Investor Inquiries, Andrew Floor, Dixie Brands Inc, / 707-294-8392

More Press Releases